Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP288449.RAfuSgYrynvwUoCZ2PyV7kHTrUP01EOT1-mC2Slj3JIhQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP288449.RAfuSgYrynvwUoCZ2PyV7kHTrUP01EOT1-mC2Slj3JIhQ130_assertion type Assertion NP288449.RAfuSgYrynvwUoCZ2PyV7kHTrUP01EOT1-mC2Slj3JIhQ130_head.
- NP288449.RAfuSgYrynvwUoCZ2PyV7kHTrUP01EOT1-mC2Slj3JIhQ130_assertion description "[In addition, the expression of Cdk9 and Cyclin T1 was evaluated by immunohistochemistry in samples of neuroblastoma, PNET (Primary Neuroectodermal Tumor) and astrocytoma tumors of different grades, in order to assess whether there was a correlation between Cdk9 expression and tumor grading.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP288449.RAfuSgYrynvwUoCZ2PyV7kHTrUP01EOT1-mC2Slj3JIhQ130_provenance.
- NP288449.RAfuSgYrynvwUoCZ2PyV7kHTrUP01EOT1-mC2Slj3JIhQ130_assertion evidence source_evidence_literature NP288449.RAfuSgYrynvwUoCZ2PyV7kHTrUP01EOT1-mC2Slj3JIhQ130_provenance.
- NP288449.RAfuSgYrynvwUoCZ2PyV7kHTrUP01EOT1-mC2Slj3JIhQ130_assertion SIO_000772 15753651 NP288449.RAfuSgYrynvwUoCZ2PyV7kHTrUP01EOT1-mC2Slj3JIhQ130_provenance.
- NP288449.RAfuSgYrynvwUoCZ2PyV7kHTrUP01EOT1-mC2Slj3JIhQ130_assertion wasDerivedFrom befree-20150227 NP288449.RAfuSgYrynvwUoCZ2PyV7kHTrUP01EOT1-mC2Slj3JIhQ130_provenance.
- NP288449.RAfuSgYrynvwUoCZ2PyV7kHTrUP01EOT1-mC2Slj3JIhQ130_assertion wasGeneratedBy ECO_0000203 NP288449.RAfuSgYrynvwUoCZ2PyV7kHTrUP01EOT1-mC2Slj3JIhQ130_provenance.